Tenva Capital
Subscribe
Sign in
Home
Chat
Open Ideas
Closed Ideas
Case Studies
Archive
About
Open Ideas
Challenger Gold (CEL:ASX)
2.6x NTM EV/EBITDA. 75% of Today's Market Cap to be Generated in FCF Over Next 3 Years.
Nov 10
•
Tenva Capital
6
Pioneer Credit: FY25 Update
Earnings Beat. Inflection on Track.
Aug 27
•
Tenva Capital
5
2
Sanuwave Health: Q2 Update
Continued Execution.
Aug 11
•
Tenva Capital
21
9
Select Harvests (SHV:ASX)
Structurally Broken Supply with Material Impending Cashflow Generation.
Aug 7
•
Tenva Capital
36
41
5
Matrix Composites & Engineering (MCE:ASX)
~1.9x EV/EBITDA, Operating Leverage, Near-term Earnings Catalysts and Major LT Growth Optionality.
Jun 25
•
Tenva Capital
24
15
2
Updates: Sanuwave and Pioneer
Underwriting the book to date
Jun 3
•
Tenva Capital
10
Sanuwave Health (SNWV:NASDAQ)
Is this the Fastest-Growing, Profitable Medical Device Company in U.S. Wound Care?
May 9
•
Tenva Capital
36
6
2
Diamond in the rough (PNC:ASX)
3x FY26 P/E, 0.3x conservative liquidation value with multiple near-term catalysts on the horizon.
Apr 15
•
Tenva Capital
11
12
2
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts